AKYNZEO
NDC 69639-101, Netupitant and Palonosetron, capsule, from Helsinn Therapeutics (U.S.), Inc..
- Product NDC
- 69639-101
- Status
- Listed
- Labeler
- Helsinn Therapeutics (U.S.), Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205718
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69639-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NETUPITANT300 mg/1
- PALONOSETRON.5 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]; Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69639-101-01 | 69639010101 | 1 BLISTER PACK in 1 CARTON (69639-101-01) / 1 CAPSULE in 1 BLISTER PACK |
| 69639-101-04 | 69639010104 | 2 BLISTER PACK in 1 CARTON (69639-101-04) / 2 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8e47618e-af46-4d82-94e8-1507c042252dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=69639-101
Use it
Look up 69639-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69639-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69639-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.